29.11.2021   

EN

Official Journal of the European Union

C 481/24


Judgment of the General Court of 6 October 2021 — Dermavita Company v EUIPO — Allergan Holdings France (JUVEDERM)

(Case T-372/20) (1)

(EU trade mark - Revocation proceedings - EU word mark JUVEDERM - Genuine use of the mark - Use in connection with the goods in respect of which the mark is registered - Use with the consent of the proprietor - Article 51(1)(a) of Regulation (EC) No 207/2009 (now Article 58(1)(a) of Regulation (EU) 2017/1001))

(2021/C 481/33)

Language of the case: English

Parties

Applicant: Dermavita Company S.a.r.l. (Beirut, Lebanon) (represented by: D. Todorov, lawyer)

Defendant: European Union Intellectual Property Office (represented by: K. Zajfert, J. Crespo Carrillo and V.J. Ruzek, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Allergan Holdings France SAS (Courbevoie, France) (represented by: J. Day, Solicitor, and T. de Haan, lawyer)

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 14 April 2020 (Case R 877/2019-4), relating to revocation proceedings between Dermavita Company and Allergan Holdings France.

Operative part of the judgment

The Court:

1.

Dismisses the action;

2.

Orders Dermavita Company S.a.r.l. to pay the costs of the present proceedings.


(1)  OJ C 262, 10.8.2020.